Back to Results
First PageMeta Content
Health / Artemisinin / The International Pharmacopoeia / Validation / Good manufacturing practice / Dihydroartemisinin / Counterfeit medications / Verification and validation / Artemisia annua / Pharmaceutical industry / Pharmaceutical sciences / Technology


Microsoft Word - StartingMaterials-QAS10-349.doc
Add to Reading List

Document Date: 2010-04-25 04:58:29

Open Document

File Size: 299,13 KB

Share Result on Facebook

City

Geneva / /

Company

Aventis / QAS / Sanofi / Quality Control Laboratories / Malaria Venture / /

Country

Switzerland / /

/

Event

Person Communication and Meetings / /

/

IndustryTerm

finished pharmaceutical product / manufacturing authorization / pharmaceutical ingredient / empirical tools / final product / active pharmaceutical ingredient / pharmaceutical industry / drug product / finished pharmaceutical products / manufacturing practices / medicinal product / defined chemical properties / manufacturing / manufacturing practice / pharmaceutical customers / drug products / active pharmaceutical ingredients http /

Organization

World Health Organization / forty-fifth WHO Expert Committee on Specifications for Pharmaceutical Preparations / European Medicines Agency / Department of Medicines Policy and Standards / /

Person

I. Bathurst / R.W. Stringham / Sabine Kopp / A.J. van Zyl / /

Position

Director / Drug Access Team Clinton Health Access Initiative / Scientific Director / Drug Access Team / Manager / Medicines Quality Assurance Programme / Essential Medicines and Pharmaceutical Policies / API producer / producer / Head / Head of Inspections / /

Technology

API / crystallization / /

URL

http /

SocialTag